Unilever Consumer Care Limited announcements
322 Dhaka Stock Exchange announcements for Unilever Consumer Care Limited (UNILEVERCL) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2018 (26).
- The Company has informed that the Board of Directors has been informed vide a notification letter on December 03, 2018 f
The Company has informed that the Board of Directors has been informed vide a notification letter on December 03, 2018 from SETFIRST Limited (Setfirst), a shareholder/member of the Company, that Setfirst has signed a Share Purchase Agreement on December 03, 2018 (the SPA) (cont.)
Posted under the former code GLAXOSMITH. - (Continuation news of GLAXOSMITH): to sell and dispose 9,875,144 shares in the Company to Unilever N.V. (The Transaction
(Continuation news of GLAXOSMITH): to sell and dispose 9,875,144 shares in the Company to Unilever N.V. (The Transaction). The transaction is subject to the satisfaction or waiver of the conditions precedents in the SPA (including necessary regulatory formalities and approval in accordance with the laws of Bangladesh). (end)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Com
In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike of shares.
Posted under the former code GLAXOSMITH. - The Company has informed that the Board of Directors has appointed Mr. Prashant Pandey as the Managing Director of the C
The Company has informed that the Board of Directors has appointed Mr. Prashant Pandey as the Managing Director of the Company with effect from December 01, 2018.
Posted under the former code GLAXOSMITH. - (Q3 Un-audited): EPS was Tk. (48.64) for July-September 2018 as against Tk. 20.50 for July-September 2017; EPS was Tk. (
(Q3 Un-audited): EPS was Tk. (48.64) for July-September 2018 as against Tk. 20.50 for July-September 2017; EPS was Tk. (33.50) for January-September 2018 as against Tk. 39.78 for January-September 2017. NOCFPS was Tk. 52.41 for January-September 2018 as against Tk. 94.74 for January-September 2017. NAV per share was Tk. 129.85 as on September 30, 2018 and Tk. 204.43 as on September 30, 2017. It is to be noted that the closure of the operation of pharmaceutical segment of the entity and (cont.)
Posted under the former code GLAXOSMITH. - (Continuation news of GLAXOSMITH): the subsequent approval by shareholders. Closure of pharmaceutical operation involves
(Continuation news of GLAXOSMITH): the subsequent approval by shareholders. Closure of pharmaceutical operation involves significant amount of costs in terms of severance payment to employees, impairment of non-current assets and inventory write-off. Part of these closure cost have been charged in Q3 2018. Consideration of these expenses affected financial result of the entity leading to significant deviation between EPS, NAV and NOCFPS of Q3 2018 and those of comparative period. (end)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 31, 2018 at 5:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2018.
Posted under the former code GLAXOSMITH. - The Company has further informed that the EGM of the Company will be held at Utshab Hall (Ground Level), Radission Blu D
The Company has further informed that the EGM of the Company will be held at Utshab Hall (Ground Level), Radission Blu Dhaka Water Garden, Airport Road, Dhaka Cantonment, Dhaka-1206 on October 14, 2018 at 11:00 AM. Other information will remain unchanged.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will resume on 20.09.2018 after record date.
Trading of the shares of the Company will resume on 20.09.2018 after record date.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will remain suspended on record date i.e., 19.09.2018 for EGM.
Trading of the shares of the Company will remain suspended on record date i.e., 19.09.2018 for EGM.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle from 17.09.2018 to 18.09.2018. Trading of the shares of the Company will remain suspended on record date i.e., 19.09.2018 for EGM.
Posted under the former code GLAXOSMITH. - Referring to their earlier news disseminated on 29.07.2018 in connection with closure of Manufacturing & Commercial oper
Referring to their earlier news disseminated on 29.07.2018 in connection with closure of Manufacturing & Commercial operations of their Pharmaceuticals Business, subject to approval by the Shareholders in the EGM, the Company has further informed that the Board of Directors has now taken decision to hold an EGM on 14th October 2018 at 11:00 AM to consider and approve the above agenda. (cont.)
Posted under the former code GLAXOSMITH. - (Continuation news of GLAXOSMITH): Venue of the EGM will be notified later. Record date for EGM: September 19, 2018. The
(Continuation news of GLAXOSMITH): Venue of the EGM will be notified later. Record date for EGM: September 19, 2018. The Company has further informed that changes in the pharmaceuticals business operations by the Company in Bangladesh will have no impact on the consumer healthcare business in Bangladesh. (end)
Posted under the former code GLAXOSMITH. The first part of this announcement is missing from the archive. - The Company has informed that the Board of Directors has recommended the closure of the manufacturing and commercial ope
The Company has informed that the Board of Directors has recommended the closure of the manufacturing and commercial operations of the pharmaceutical business of GSK. This recommendation is subject to the Extra Ordinary General Meeting of GSK to be held. The GSK Bangladesh entity continues with the ongoing Consumer Healthcare business which is not impacted by the changes in the Pharmaceutical operations.
Posted under the former code GLAXOSMITH. - (Q2 Un-audited): EPS was Tk. 3.65 for April-June 2018 as against Tk. 4.61 for April-June 2017; EPS was Tk. 15.14 for Jan
(Q2 Un-audited): EPS was Tk. 3.65 for April-June 2018 as against Tk. 4.61 for April-June 2017; EPS was Tk. 15.14 for January-June 2018 as against Tk. 19.27 for January-June 2017. NOCFPS was Tk. 29.94 for January-June 2018 as against Tk. 42.39 for January-June 2017. NAV per share was Tk. 178.49 as on June 30, 2018 and Tk. 183.93 as on June 30, 2017.
Posted under the former code GLAXOSMITH. - As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 22, 2018 at 6:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on June 30, 2018.
Posted under the former code GLAXOSMITH. - The Company has informed that the Board of Directors has appointed Mr. Mohammed Azizul Huq as the Chairman and Mr. Nakib
The Company has informed that the Board of Directors has appointed Mr. Mohammed Azizul Huq as the Chairman and Mr. Nakibur Rahman as the Managing Director of the Company, with effect from July 01, 2018.
Posted under the former code GLAXOSMITH. - The Company has informed that it has remitted cash dividend for the year ended on December 31, 2017 to the respective sh
The Company has informed that it has remitted cash dividend for the year ended on December 31, 2017 to the respective shareholders' Bank Account through BEFTN system.
Posted under the former code GLAXOSMITH. - (Q1 Un-audited): EPS was Tk. 11.49 for January-March, 2018 as against Tk. 14.66 for January-March, 2017; NOCFPS was Tk.
(Q1 Un-audited): EPS was Tk. 11.49 for January-March, 2018 as against Tk. 14.66 for January-March, 2017; NOCFPS was Tk. 3.76 for January-March, 2018 as against Tk. 12.54 for January-March, 2017. NAV per share was Tk. 229.84 as on March 31, 2018 and Tk. 229.31 as on March 31, 2017.
Posted under the former code GLAXOSMITH. - As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 19, 2018 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on March 31, 2018.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will resume on 22.03.2018 after record date.
Trading of the shares of the Company will resume on 22.03.2018 after record date.
Posted under the former code GLAXOSMITH. - Trading of the shares of the Company will remain suspended on record date i.e., 21.03.2018.
Trading of the shares of the Company will remain suspended on record date i.e., 21.03.2018.
Posted under the former code GLAXOSMITH. - Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 19.03.2018 to 20.03.2018. Trading of the shares of the Company will remain suspended on record date i.e., 21.03.2018.
Posted under the former code GLAXOSMITH. - The Board of Directors has recommended 550% cash dividend for the year ended on December 31, 2017. Date of AGM: 19.04.20
The Board of Directors has recommended 550% cash dividend for the year ended on December 31, 2017. Date of AGM: 19.04.2018, Time: 11:00 AM, Venue: Radisson Blu Chittagong Bay view, Chittagong. Record date: 21.03.2018. The Company has also reported EPS of Tk. 55.56, NAV per share of Tk. 218.35 and NOCFPS of Tk. 117.74 for the year ended on December 31, 2017 as against Tk. 53.51, Tk. 214.65 and Tk. 71.86 respectively for the same period of the previous year.
Posted under the former code GLAXOSMITH. - There will be no price limit on the trading of the shares of the Company today (28.02.2018) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (28.02.2018) following its corporate declaration.
Posted under the former code GLAXOSMITH. - As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 27, 2018 at 4:30 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2017.
Posted under the former code GLAXOSMITH.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.